AstraZeneca’s Q4 revenue down by 7% to $11.21B



AstraZeneca PLC announced on Thursday its revenue in the fourth quarter of the fiscal year 2022 saw an annual decrease of 7% to come in at $11.21 billion. Its product sales declined by 6% compared to …
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento